Role of opiate peptides in regulating energy balance

Neurobiology of Obesity

Volumn , Issue , 2008, Pages 232-265

  Bodnar, Richard J ^a   Levine, Allen S ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b University of Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 41949115375     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511541643.009     Document Type: Chapter

References (280)

1. Abrahamsen, G. C., Berman, Y. & Carr, K. D. (1995). Curve-shift analysis of selfstimulation in food restricted rats: relationship between daily meal, plasma corticosterone and reward sensitization. Brain Res. 695, 186–94.
2. Akil, H., Watson, S. J., Young, E. et al. (1984). Endogenous opioids: biology and function. Annu. Rev. Neurosci. 7, 223–55.
3. Apfelbaum, M. & Mandenoff, A. (1981). Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet. Pharmacol. Biochem. Behav. 15, 89–91.
4. Appleyard, S. M., Haywood, M., Young, J. I. et al. (2003). A role for the endogenous opioid beta-endorphin in energy homeostasis. Endocrinology 144, 1753–60.
5. Aravich, P. F., Rieg, T. S., Lauterio, T. J. & Doerries, L. E. (1993). Beta-endorphin and dynorphin abnormalities in rats subjected to exercise and restricted feeding: relationship to anorexia nervosa? Brain Res. 622, 1–8.
6. Arbisi, P. A., Billington, C. J. & Levine, A. S. (1999). The effect of naltrexone on taste detection and recognition threshold. Appetite 32, 241–9.
7. Arjune, D. & Bodnar, R. J. (1990). Suppression of nocturnal, palatable and glucoprivic intake in rats by the kappa opioid antagonist, nor-binaltorphamine. Brain Res. 534, 313–16.
8. Arjune, D., Standifer, K. M., Pasternak, G. W. & Bodnar, R. J. (1990). Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Brain Res. 535, 101–9.
9. Arjune, D., Bowen, W. D. & Bodnar, R. J. (1991). Ingestive behavior following central [D-Ala2, Leu5, Cys6]-enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptor. Pharmacol. Biochem. Behav. 39, 429–36.
10. Azzara, A. V., Bodnar, R.J, Delamater, A. R. & Sclafani, A. (2000). Naltrexone fails to block the acquisition or expression of a flavor preference conditioned by intragastric carbohydrate infusions. Pharmacol. Biochem. Behav. 67, 545–57.
11. Badiani, A., Leone, P., Noel, M. B. & Stewart, J. (1995). Ventral tegmental area opioid mechanisms and modulation of ingestive behavior. Brain Res. 670, 264–76.
12. Baker, R. W., Li, Y., Lee, M. G., Sclafani, A. & Bodnar, R. J. (2004). Naltrexone does not prevent acquisition or expression of flavor preferences conditioned by fructose in rats. Pharmacol. Biochem. Behav. 78, 239–46.
13. Bakshi, V. P. & Kelley, A. E. (1993a). Feeding induced by opioid stimulation of the ventral striatum: role of opioid receptor subtypes. J. Pharmacol. Exp. Ther. 265, 1253–60.
14. Bakshi, V. P. & Kelley, A. E. (1993b). Striatal regulation of morphine-induced hyperphagia: an anatomical mapping study. Psychopharmacology 111, 207–14.
15. Barnes, M. J., Lapanowski, K., Conley, A., Rafols, J. A., Jen, K. L. & Dunbar, J. C. (2003). High fat feeding is associated with increased blood pressure, sympathetic nerve activity and hypothalamic mu opioid receptors. Brain Res. Bull. 61, 511–19.
16. Barton, C., York, D. A. & Bray, G. A. (1996). Opioid receptor subtype control of galanin-induced feeding. Peptides 17, 237–40.
17. Beczkowska, I. W. & Bodnar, R. J. (1991). Mediation of insulin hyperphagia by specific central opiate receptor antagonists. Brain Res. 547, 315–18.
18. Beczkowska, I. W., Bowen, W. D. & Bodnar, R. J. (1992). Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in rats. Brain Res. 589, 291–301.
19. Beczkowska, I. W., Koch, J. E., Bostock, M. E., Leibowitz, S. F. & Bodnar, R. J. (1993). Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats. Brain Res. 618, 261–70.
20. Berman, Y., Devi, L. & Carr, K. D. (1994). Effects of chronic food restriction on prodynorphin-derived peptides in rat brain regions. Brain Res. 664, 49–53.
21. Berman, Y., Devi, L. & Carr, K. D. (1995). Effects of streptozotocin-induced diabetes on prodynorphin-derived peptides in rat brain regions. Brain Res. 685, 129–34.
22. Berman, Y., Devi, L., Spangler, R., Kreek, M. J. & Carr, K. D. (1997). Chronic food restriction and streptozotocin-induced diabetes differentially alter prodynorphin mRNA levels in rat brain regions. Mol. Brain Res. 46, 25–30.
23. Bertiere, M. C., Mame Sy, T., Baigts, F., Mandenoff, A. & Apfelbaum, M. (1984). Stress and sucrose hyperphagia: role of endogenous opiates. Pharmacol. Biochem. Behav. 20, 675–9.
24. Bertino, M., Beauchamp, G. K. & Engelman, K. (1991). Naltrexone, an opiate blocker, alters taste perception and nutrient intake in humans. Am. J. Physiol. 261, R59–63.
25. Bodnar, R. J. (2004). Endogenous opioids and feeding behavior: a thirty-year historical perspective. Peptides 25, 697–725.
26. Bodnar, R. J., Glass, M. J. & Koch, J. E. (1995a). Analysis of central opioid receptor subtype antagonism of hypotonic and hypertonic saline intake in waterdeprived rats. Brain Res. Bull. 36, 293–300.
27. Bodnar, R. J., Glass, M. J., Ragnauth, A. & Cooper, M. L. (1995b). General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions. Brain Res. 700, 205–12.
28. Bodnar, R. J., Lamonte, N., Israel, Y., Kandov, Y., Ackerman, T. F. & Khaimova, E. (2005). Reciprocal opioid-opioid interactions between the ventral tegmental area and nucleus accumbens regions in mediating mu agonist-induced feeding in rats. Peptides 26, 621–9.
29. Bozarth, M. A. & Wise, R. A. (1981). Intracranial self-administration of morphine into the ventral tegmental area. Life Sci. 28, 551–5.
30. Brands, B. J., Thornhill, J. A., Hirst, M. & Gowdey, C. W. (1979). Suppression of food intake and body weight by naloxone in rats. Life Sci. 24, 1773–8.
31. Brown, D. R. & Holtzman, S. J. (1979). Suppression of deprivation induced food and water intake in rats and mice by naloxone. Pharmacol. Biochem. Behav. 11, 567–83.
32. Brown, D. R. & Holtzman, S. G. (1980). Evidence that opiate receptors mediate suppression of hypertonic saline-induced drinking in the mouse by narcotic antagonists. Life Sci. 26, 1543–50.
33. Brown, D. R., Blank, M. S. & Holtzman, S. G. (1980). Suppression by naloxone of water intake induced by deprivation and hypertonic saline in intact and hypophysectomized rats. Life Sci. 26, 1535–42.
34. Brugman, S., Clegg, D. J., Woods, S. C. & Seeley, R. J. (2002). Combined blockade of both mu- and kappa-opioid receptors prevents the acute orexigenic action of agouti-related protein. Endocrinology 143, 4265–70.
35. Burdick, K., Yu, W.-Z., Ragnauth, A. et al. (1998). Antisense mapping of opioid receptor clones: effects upon 2-deoxy-D-glucose-induced hyperphagia. Brain Res. 794, 359–63.
36. Cador, M., Kelley, A. E., LeMoal, M. & Stinus, L. (1986). Ventral tegmental area infusion of substance P, neurotensin and enkephalin: differential effects on feeding behavior. Neuroscience 18, 659–69.
37. Canli, T., Cook, R. G. & Miczek, K. A. (1990). Opiate antagonists enhance the working memory of rats in the radial maze. Pharmacol. Biochem. Behav. 36, 521–5.
38. Carr, K. D. (1990). Effects of antibodies to dynorphin A and beta-endorphin on lateral hypothalamic self-stimulation in ad libitum fed and food-deprived rats. Brain Res. 534, 8–14.
39. Carr, K. D. & Bak, T. H. (1990). Rostral and caudal ventricular infusion of antibodies to dynorphin A (1–17) and dynorphin A (1–8): effects on electrically-elicited feeding in the rat. Brain Res. 507, 289–94.
40. Carr, K. D. & Simon, E. J. (1983). Effects of naloxone and its quatenary analogue on stimulation-induced feeding. Neuropharmacology 22, 127–30.
41. Carr, K. D., Bak, T. H., Gioannini, T. L. & Simon, E. J. (1987). Antibodies to dynorphin A(1–13) but not beta-endorphin inhibit electrically-elicited feeding in the rat. Brain Res. 422, 384–8.
42. Carr, K. D., Bak, T. H., Simon, E. J. & Portoghese, P. S. (1989). Effects of the selective K opioid antagonist, nor-binaltorphamine, on electrically-elicited feeding in the rat. Life Sci. 45, 1787–92.
43. Carr, K. D., Aleman, D. O., Bak, T. H. & Simon, E. J. (1991). Effects of parabrachial opioid antagonism on stimulation-induced feeding. Brain Res. 545, 283–6.
44. Carr, K. D., Papadouka, V. & Wolinsky, T. D. (1993). Norbinaltorphamine blocks the feeding but not the reinforcing effect of lateral hypothalamic electrical stimulation. Psychopharmacology 111, 345–50.
45. Carr, K. D., Park, T. H. & Stone, E. A. (1998). Neuroanatomical patterns of Fos-like immunoreactivity induced by naltrexone in food-restricted and ad libitum fed rats. Brain Res. 779, 26–32.
46. Carr, K. D., Kutchukhidze, N. & Park, T. H. (1999). Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala. Brain Res. 822, 34–42.
47. Clark, J. A., Liu, L., Price, M., Hersh, B., Edelson, M. & Pasternak, G. W. (1989). Kappa opiate receptor multiplicity: evidence for two U50,488H-sensitive K-1 subtypes and a novel K-3 subtype. J. Pharmacol. Exp. Ther. 251, 461–8.
48. Colantuoni, C., Schwenker, J., McCarthy, J. et al. (2001). Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport 12, 3549–52.
49. Colantuoni, C., Rada, P., McCarthy, J. et al. (2002). Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence. Obes. Res. 10, 478–88.
50. Cole, J. L., Leventhal, L., Pasternak, G. W., Bowen, W. D. & Bodnar, R. J. (1995). Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Brain Res. 678, 168–76.
51. Cole, J. L., Berman, N. & Bodnar, R. J. (1997). Evaluation of chronic opioid receptor antagonist effects upon weight and intake measures in lean and obese Zucker rats. Peptides 18, 1201–7.
52. Cole, J. L., Ross, A. & Bodnar, R. J. (1999). Dietary history affects the potency of chronic opioid receptor subtype antagonist effects upon body weight in rats. Nutr. Neurosci. 1, 405–18.
53. Cooper, S. J. (1980). Naloxone: effects on food and water consumption in the non-deprived and deprived rat. Psychopharmacology 71, 1–6.
54. Cooper, S. J. (1981). Behaviorally-specific hyperdipsia in the non-dependent rat following acute morphine treatment. Neuropharmacology 20, 469–72.
55. Cooper, S. J. & Gilbert, D. B. (1984). Naloxone suppresses fluid consumption in tests of choice between sodium chloride solutions and water in male and female water-deprived rats. Psychopharmacology 84, 362–7.
56. Cooper, S. J., Barber, D. J. & Barber-McMullen, J. (1985a). Selective attenuation of sweetened milk consumption by opiate receptor antagonists in male and female rats of the Roman strains. Neuropeptide 5, 349–52.
57. Cooper, S. J., Jackson, A. & Kirkham, T. C. (1985b). Endorphins and food intake: K opioid receptor agonists and hyperphagia. Pharmacol. Biochem. Behav. 23, 889–901.
58. Cooper, S. J., Jackson, A., Morgan, R. & Carter, R. (1985c). Evidence for opiate receptor involvement in the consumption of a high palatability diet in non-deprived rats. Neuropeptide 5, 345–8.
59. Cooper, S. J., Moores, W. R., Jackson, A. & Barber, D. J. (1985d). Effects of tifluadom on food consumption compared with chlordiazepoxide and kappa agonists. Neuropharmacology 24, 877–83.
60. Czech, D. A. & Stein, E. A. (1980). Naloxone suppresses osmoregulatory drinking in rats. Pharmacol. Biochem. Behav. 12, 987–9.
61. Czech, D. A., Stein, E. A. & Blake, M. J. (1983). Naloxone-induced hypodipsia: a CNS mapping study. Life Sci. 33, 797–803.
62. Czech, D. A., Blake, M. J. & Stein, E. A. (1984). Drinking behavior is modulated by CNS administration of opioids. Appetite 5, 15–24.
63. DeCaro, G., Micossi, L. G. & Venturi, F. (1979). Drinking behavior induced by intracerebroventricular enkephalins in rats. Nature 277, 51–3.
64. Delamater, A. R., Sclafani, A. & Bodnar, R. J. (2000). Pharmacology of sucrosereinforced place-preference conditioning: effects of naltrexone. Pharmacol. Biochem. Behav. 65, 697–704.
65. Devine, D. P. & Wise, R. A. (1994). Self-administration of morphine, DAMGO and DPDPE into the ventral tegmental area of rats. J. Neurosci. 14, 1978–84.
66. Drewnowski, A., Krahn, D. D., Demitrack, M. A., Nairn, K. & Gosnell, B. A. (1992). Taste responses and preferences for sweet high-fat foods: evidence for opioid involvement. Physiol. Behav. 51, 371–9.
67. Evans, K. R. & Vaccarino, F. J. (1990). Amphetamine- and morphine-induced feeding: evidence for involvement of reward mechanisms. Neurosci. Biobehav. Rev. 14, 9–22.
68. Fantino, M., Hosotte, J. & Apfelbaum, M. (1986). An opioid antagonist naltrexone, reduces the preference for sucrose in humans. Am. J. Physiol. 251, R91–6.
69. Frenk, H. & Rogers, G. H. (1979). The suppressant effects of naloxone on food and water intake in the rat. Behav. Neur. Biol. 26, 23–40.
70. Giraudo, S. Q., Billington, C. J. & Levine, A. S. (1998a). Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the central nucleus of the amygdala and in the paraventricular nucleus in the rat. Brain Res. 782, 18–23.
71. Giraudo, S. Q., Kotz, C. M., Billington, C. J. & Levine, A. S. (1998b). Association between the amygdala and the nucleus of the solitary tract in mu opioid induced feeding in the rat. Brain Res. 802, 184–8.
72. Glass, M. J., Hahn, B., Joseph, A. & Bodnar, R. J. (1994). Central opioid receptor subtype mediation of isoproterenol-induced drinking in rats. Brain Res. 657, 310–14.
73. Glass, M. J., Grace, M., Cleary, J. P., Billington, C. J. & Levine, A. S. (1996). Potency of naloxone’s anorectic effect in rats is dependent on diet preference. Am. J. Physiol. 271, R217–21.
74. Glass, M. J., Billington, C. J. & Levine, A. S. (2000). Naltrexone administered to central nucleus of amygdala or PVN: neural dissociation of diet and energy. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R86–92.
75. Goldstein, A., Fischli, W., Lowney, L. I., Hunkapiller, M. & Hood, L. (1981). Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. Proc. Natl. Acad. Sci. USA 74, 7219–23.
76. Gosnell, B. A. (1988). Involvement of mu opioid receptors in the amygdala in the control of feeding. Neuropharmacology 27, 319–26.
77. Gosnell, B. A. & Majchrzak, M. J. (1989). Centrally administered opioid peptides stimulate saccharin intake in nondeprived rats. Pharmacol. Biochem. Behav. 33, 805–10.
78. Gosnell, B. A. & Majchrzak, M. J. (1990). Effects of a selective mu opioid receptor agonist and naloxone on the intake of sodium chloride solutions. Psychopharmacology 100, 66–71.
79. Gosnell, B. A., Levine, A. S. & Morley, J. E. (1986a). The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors. Life Sci. 38, 1081–8.
80. Gosnell, B. A., Morley, J. E. & Levine, A. S. (1986b). Opioid-induced feeding: localization of sensitive brain sites. Brain Res. 369, 177–84.
81. Gosnell, B. A., Grace, M. & Levine, A. S. (1987). Effects of beta-chlornaltrexamine on food intake, body weight and opioid-induced feeding. Life Sci. 40, 1459–67.
82. Gosnell, B. A., Krahn, D. D. & Majchrzak, M. J. (1990a). The effects of morphine on diet selection are dependent upon baseline diet preferences. Pharm. Biochem. Behav. 37, 207–12.
83. Gosnell, B. A., Majchrzak, M. J. & Krahn, D. D. (1990b). Effects of preferential delta and kappa opioid receptor agonists on the intake of hypotonic saline. Physiol. Behav. 47, 601–3.
84. Grandison, L. & Guidotti, A. (1977). Stimulation of food intake by muscimol and beta-endorphin. Neuropharmacology 16, 533–6.
85. Grossman, H. C., Hadjimarkou, M. M., Silva, R. M., Giraudo, S. Q. & Bodnar, R. J. (2003). Interrelationships between mu opioid and melanocortin receptors in mediating food intake in rats. Brain Res. 991, 240–4.
86. Hadjimarkou, M. M., Silva, R. M., Rossi, G. C., Pasternak, G. W. & Bodnar, R. J. (2002). Feeding induced by food deprivation is differentially reduced by G-protein alpha-subunit antisense probes in rat. Brain Res. 955, 45–54.
87. Hadjimarkou, M.M., Khaimova, E., Pan, Y.-X., Rossi, G. C., Pasternak, G.W. & Bodnar, R. J. (2003). Feeding induced by food deprivation is differentially reduced by opioid receptor antisense oligodeoxynucleotide probes in rats. Brain Res. 987, 223–32.
88. Hadjimarkou, M. M., Singh, A., Kandov, Y. et al. (2004). Opioid receptor involvement in food deprivation-induced feeding: evaluation of selective antagonist and antisense oligodeoxynucleotides probe effects in mice and rats. J. Pharmacol. Exp. Ther. 311, 1188–202.
89. Hagan, M. M. & Moss, D. E. (1991). An animal model of bulimia nervosa: opioid sensitivity to fasting episodes. Pharmacol. Biochem. Behav. 39, 421–2.
90. Hamilton, M. E. & Bozarth, M. A. (1988). Feeding elicited by dynorphin (1–13) microinjections into the ventral tegmental area. Life Sci. 43, 941–6.
91. Hawkins, M. F., Cubic, B., Baumeister, A. A. & Bartin, C. (1992). Microinjection of opioid antagonists into the substantia nigra reduces stress-induced eating in rats. Brain Res. 584, 261–5.
92. Haywood, M. D. & Low, M. J. (2005). Naloxone’s suppression of spontaneous and food-conditioned locomotor activity is diminished in mice lacking either the dopamine D(2) receptor or enkephalin. Mol. Brain Res. 140, 91–8.
93. Haywood, M. D., Pintar, J. E. & Low, M. J. (2002). Selective reward deficit in mice lacking beta-endorphin and enkephalin. J. Neurosci. 22, 8251–8.
94. Haywood, M. D., Hansen, S. T., Pintar, J. E. & Low, M. J. (2004). Operant selfadministration of ethanol in C57BL/6 mice lacking beta-endorphin and enkephalin. Pharmacol. Biochem. Behav. 79, 171–81.
95. Holtzman, S. G. (1974). Behavioral effects of separate and combined administration of naloxone and d-amphetamine. J. Pharmacol. Exp. Ther. 189, 51–60.
96. Holtzman, S. G. (1975). Effects of narcotic antagonists on fluid intake in the rat. Life Sci. 16, 1465–70.
97. Hughes, J., Smith, T., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A. & Morris, H. R. (1975). Identification of two related penta-peptides from the brain with potent opiate agonist activity. Nature 258, 577–9.
98. Israel, Y., Kandov, Y., Kest, A., Lewis, S. R. & Bodnar, R. J. (2005). Neuropeptide Y-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats. Peptides 26, 1167–75.
99. Jackson, A. & Cooper, S. J. (1985). Effects of K opiate agonists on palatable food consumption in non-deprived rats with and without food preloads. Brain Res. Bull. 15, 391–6.
100. Jackson, A. & Cooper, S. J. (1986). An observational analysis of the effect of the selective kappa opioid agonist, U50488H, on feeding and related behaviors in the rat. Psychopharmacology 90, 217–21.
101. Jackson, H. C. & Sewell, R. D. E. (1985a). Are delta opioid receptors involved in the regulation of food and water intake? Neuropharmacology 24, 885–8.
102. Jackson, H. C. & Sewell, R. D. E. (1985b). Hyperphagia induced by 2-deoxy-D-glucose in the presence of the delta-opioid antagonist, ICI174864. Neuropharmacology 24, 815–17.
103. Jalowiec, J. E., Panksepp, J., Zolovick, A. J., Najam, N. & Herman, B. (1981). Opioid modulation of ingestive behavior. Pharmacol. Biochem. Behav. 15, 477–84.
104. Jenck, F., Gratton, A. & Wise, R. A. (1986). Opioid receptor subtypes associated with ventral tegmental facilitation and periaqueductal gray inhibition of feeding. Brain Res. 423, 39–44.
105. Jenck, F., Gratton, A. & Wise, R. A. (1987). Opioid receptor subtypes associated with ventral tegmental area facilitation of lateral hypothalamic brain stimulation reward. Brain Res. 423, 34–8.
106. Jewett, D. C., Grace, M. K., Jones, R. M. et al. (2001). The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats. Brain Res. 909, 75–80.
107. Jiang, Q., Takemori, A. E., Sultana, M. et al. (1991). Differential antagonism of opioid delta antinociception by [D-Ala2, Leu5, Cys6]-enkephalin (DALCE) and naltrindole 50-isothiocyanate (50-NTII): evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 257, 1069–75.
108. Jones, J. E. & Corp, E. S. (2003). Effect of naltrexone on food intake and body weight in Syrian hamsters depends on metabolic status. Physiol. Behav. 78, 67–72.
109. Kangawa, K., Minamino, N., Chino, N., Sakakibara, S. & Matsuo, H. (1981). The complete amino acid sequence of alpha-neo-endorphin. Biochem. Biophys. Res. Commun. 99, 871–8.
110. Kelley, A. E., Bless, E. P. & Swanson, C. J. (1996). Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats. J. Pharmacol. Exp. Ther. 278, 1499–507.
111. Kelley, A. E., Will, M. J., Steininger, T. L., Zhang, M. & Haber, S. N. (2003). Restricted daily consumption of a highly palatable food (chocolate Ensure(R)) alters striatal enkephalin gene expression. Eur. J. Neurosci. 18, 2592–8.
112. Kieffer, B. L. (1995). Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell. Mol. Neurobiol. 15, 615–35.
113. Kim, E.-M., Welch, C. C., Grace, M. K., Billington, C. J. & Levine, A. S. (1996). Chronic food restriction and acute food deprivation decrease mRNA levels of opioid peptides in the arcuate nucleus. Am. J. Physiol. 270, R1019–24.
114. Kim, E.-M., Grace, M. K., Welch, C. C., Billington, C. J. & Levine, A. S. (1999). STZinduced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats. Am. J. Physiol. 276, R1320–6.
115. Kimura, S., Lewis, R. V., Stern, A. S., Rossier, J., Stein, S. & Undenfriend, S. (1980). Probable precursors of (leu) and (met)-enkephalin in adrenal medulla: peptides of 3–5 kilodaltons. Proc. Natl. Acad. Sci. USA 77, 1681–5.
116. King, B. M., Castellanos, F. X., Kastin, A. J. et al. (1979). Naloxone-induced suppression of food intake in normal and hypothalamic obese rats. Pharmacol. Biochem. Behav. 11, 729–32.
117. Kirkham, T. C. & Blundell, J. E. (1984). Dual action of naloxone on feeding revealed by behavioral analysis: separate effects on initiation and termination of eating. Appetite 5, 45–52.
118. Kirkham, T. C. & Blundell, J. E. (1986). Effects of naloxone and naltrexone on the development of satiation measured in the runway: comparisons with d-amphetamine and d-fenfluramine. Pharm. Biochem. Behav. 25, 123–8.
119. Kirkham, T. C. & Cooper, S. J. (1988a). Attenuation of sham feeding by naloxone is stereospecific: evidence for opioid mediation of orosensory reward. Physiol. Behav. 43, 845–7.
120. Kirkham, T. C. & Cooper, S. J. (1988b). Naloxone attenuation of sham feeding is modified by manipulation of sucrose concentration. Physiol. Behav. 44, 491–4.
121. Koch, J. E. & Bodnar, R. J. (1993). Involvement of mu-1 and mu-2 opioid receptor subtypes in tail-pinch feeding in rats. Physiol. Behav. 53, 603–5.
122. Koch, J. E., Pasternak, G. W., Arjune, D. & Bodnar, R. J. (1992). Naloxone benzoylhydrazone, a kappa-3 opioid agonist, stimulates food intake in rats. Brain Res. 581, 311–14.
123. Koch, J. E., Glass, M. J., Cooper, M. L. & Bodnar, R. J. (1995). Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of rats. Neuroscience 66, 951–7.
124. Kotz, C. M., Grace, M. K., Billington, C. J. & Levine, A. S. (1993). The effect of norbinaltorphamine, beta-funaltrexamine and naltrindole on NPY-induced feeding. Brain Res. 631, 325–8.
125. Kotz, C. M., Grace, M. K., Briggs, J., Levine, A. S. & Billington, C. J. (1995). Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action. J. Clin. Invest. 96, 163–70.
126. Kotz, C. M., Billington, C. J. & Levine, A. S. (1997). Opioids in the nucleus of the solitary tract are involved in feeding in the rat. Am. J. Physiol. 272, R1028–32.
127. Kumar, R., Mitchell, E. & Stolerman, I. P. (1971). Disturbed patterns of behaviour in morphine tolerant and abstinent rats. Br. J. Pharmacol. 42, 473–84.
128. Lamonte, N., Echo, J. A., Ackerman, T. F., Christian, G. & Bodnar, R. J. (2002). Analysis of opioid receptor subtype antagonist effects upon mu opioid agonistinduced feeding elicited from the ventral tegmental area of rats. Brain Res. 929, 96–100.
129. Leibowitz, S. F. & Hor, L. (1982). Endorphinergic and alpha-noradrenergic systems in the paraventricular nucleus: effects on eating behavior. Peptides 3, 421–8.
130. Leventhal, L. & Bodnar, R. J. (1996). Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats. Brain Res. 741, 300–8.
131. King, B. M., Castellanos, F. X., Kastin, A. J. et al. (1979). Naloxone-induced suppression of food intake in normal and hypothalamic obese rats. Pharmacol. Biochem. Behav. 11, 729–32.
132. Kirkham, T. C. & Blundell, J. E. (1984). Dual action of naloxone on feeding revealed by behavioral analysis: separate effects on initiation and termination of eating. Appetite 5, 45–52.
133. Kirkham, T. C. & Blundell, J. E. (1986). Effects of naloxone and naltrexone on the development of satiation measured in the runway: comparisons with d-amphetamine and d-fenfluramine. Pharm. Biochem. Behav. 25, 123–8.
134. Kirkham, T. C. & Cooper, S. J. (1988a). Attenuation of sham feeding by naloxone is stereospecific: evidence for opioid mediation of orosensory reward. Physiol. Behav. 43, 845–7.
135. Kirkham, T. C. & Cooper, S. J. (1988b). Naloxone attenuation of sham feeding is modified by manipulation of sucrose concentration. Physiol. Behav. 44, 491–4.
136. Koch, J. E. & Bodnar, R. J. (1993). Involvement of mu-1 and mu-2 opioid receptor subtypes in tail-pinch feeding in rats. Physiol. Behav. 53, 603–5.
137. Koch, J. E., Pasternak, G. W., Arjune, D. & Bodnar, R. J. (1992). Naloxone benzoylhydrazone, a kappa-3 opioid agonist, stimulates food intake in rats. Brain Res. 581, 311–14.
138. Koch, J. E., Glass, M. J., Cooper, M. L. & Bodnar, R. J. (1995). Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of rats. Neuroscience 66, 951–7.
139. Kotz, C. M., Grace, M. K., Billington, C. J. & Levine, A. S. (1993). The effect of norbinaltorphamine, beta-funaltrexamine and naltrindole on NPY-induced feeding. Brain Res. 631, 325–8.
140. Kotz, C. M., Grace, M. K., Briggs, J., Levine, A. S. & Billington, C. J. (1995). Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action. J. Clin. Invest. 96, 163–70.
141. Kotz, C. M., Billington, C. J. & Levine, A. S. (1997). Opioids in the nucleus of the solitary tract are involved in feeding in the rat. Am. J. Physiol. 272, R1028–32.
142. Kumar, R., Mitchell, E. & Stolerman, I. P. (1971). Disturbed patterns of behaviour in morphine tolerant and abstinent rats. Br. J. Pharmacol. 42, 473–84.
143. Lamonte, N., Echo, J. A., Ackerman, T. F., Christian, G. & Bodnar, R. J. (2002). Analysis of opioid receptor subtype antagonist effects upon mu opioid agonistinduced feeding elicited from the ventral tegmental area of rats. Brain Res. 929, 96–100.
144. Leibowitz, S. F. & Hor, L. (1982). Endorphinergic and alpha-noradrenergic systems in the paraventricular nucleus: effects on eating behavior. Peptides 3, 421–8.
145. Leventhal, L. & Bodnar, R. J. (1996). Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats. Brain Res. 741, 300–8.
146. Levine, A. S., Grace, M., Portoghese, P. S. & Billington, C. J. (1994). The effect of selective opioid antagonists on butorphanol-induced feeding. Brain Res. 637, 242–8.
147. Levine, A. S., Weldon, D. T., Grace, M., Cleary, J. P. & Billington, C. J. (1995). Naloxone blocks that portion of feeding driven by sweet taste in food-restricted rats. Am. J. Physiol. 268, R248–52.
148. Levine, A. S., Grace, M. K., Cleary, J. P. & Billington, C. J. (2002). Naltrexone infusion inhibits the development of preference for a high-sucrose diet. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R1149–54.
149. Locatelli, V., Petraglia, F., Tirloni, N. & Muller, E. E. (1986). Beta-endorphin concentrations in the hypothalamus, pituitary and plasma of streptozotocin-diabetic rats with and without insulin substitution therapy. Life Sci. 38, 379–86.
150. Locke, K. W., Brown, D. R. & Holtzman, S. G. (1982). Effects of opiate antagonists and putative mu- and kappa-agonists on milk intake in rat and squirrel monkey. Pharmacol. Biochem. Behav. 17, 1275–9.
151. Lord, J. A. H., Waterfield, A. A., Hughes, J. & Kosterlitz, H. (1977). Endogenous opioid peptides: multiple agonists and receptors. Nature 267, 495–9.
152. Low, M. J., Haywood, M. D., Appleyard, S. M. & Rubinstein, M. (2003). State-dependent modulation of feeding behavior by proopiomelanocortin-derived betaendorphin. Ann. N. Y. Acad. Sci. 994, 192–201.
153. Lowe, M. R. & Levine, A. S. (2005). Eating motives and the controversy over dieting: eating less than needed versus less than wanted. Obes. Res. 13, 797–806.
154. Lowy, M. T. & Yim, G. K. W. (1983). Stimulation of food intake following opiate agonists in rats but not hamsters. Psychopharmacology 81, 28–32.
155. Lowy, M. T., Maickel, R. P. & Yim, G. K. W. (1980). Naloxone reduction of stressrelated feeding. Life Sci. 26, 2113–18.
156. Lynch, W. C. (1986). Opiate blockade inhibits saccharin intake and blocks normal preference acquisition. Pharmacol. Biochem. Behav. 24, 833–6.
157. Lynch, W. C. & Burns, G. (1990). Opioid effects on intake of sweet solutions depend both on prior drug experience and on prior ingestive experience. Appetite 15, 23–32.
158. Lynch, W. C. & Libby, L. (1983). Naloxone suppresses intake of highly preferred saccharin solutions in food deprived and sated rats. Life Sci. 33, 1909–14.
159. MacDonald, A. F., Billington, C. J. & Levine, A. S. (2003). Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat. Am. J. Physiol. 285, R999–1004.
160. MacDonald, A. F., Billington, C. J. & Levine, A. S. (2004). Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens. Brain Res. 1018, 78–85.
161. Maickel, R. P., Braude, M. C. & Zabik, J. E. (1977). The effects of various narcotic agonists and antagonists on deprivation-induced fluid consumption. Neuropharmacology 16, 863–6.
162. Mains, R. E., Eipper, B. A. & Ling, N. (1977). Common precursor to corticotropins and endorphin. Proc. Natl. Acad. Sci. USA 197, 3014–18.
163. Majeed, N. H., Przewlocka, B., Wedzony, K. & Przewlocki, R. (1986). Stimulation of food intake following opioid microinjection into the nucleus accumbens septi in rats. Peptides 7, 711–16.
164. Mandenoff, A., Fumeron, F., Apfelbaum, M. & Margules, D. L. (1982). Endogenous opiates and energy balance. Science 215, 1536–7.
165. Mann, P. E., Arjune, D., Romero, M. T., Pasternak, G. W., Hahn, E. F. & Bodnar, R. J. (1988a). Differential sensitivity of opioid-induced feeding to naloxone and naloxonazine. Psychopharmacology 94, 330–41.
166. Mann, P. E., Pasternak, G. W., Hahn, E. F., Curreri, G., Lubin, E. & Bodnar, R. J. (1988b). Comparison of chronic naloxone and naloxonazine effects upon food intake and body weight maintainance in rats. Neuropharmacology 27, 349–55.
167. Margules, D. L., Moisset, B., Lewis, M. J., Shibuya, H. & Pert, C. B. (1978). Betaendorphin is associated with overeating in genetically-obese mice (ob/ob) and rats (fa/fa). Science 202, 988–91.
168. Marks-Kaufman, R., Balmagiya, T. & Gross, E. (1984). Modifications in food intake and energy metabolism in rats as a function of chronic naltrexone infusions. Pharmacol. Biochem. Behav. 20, 911–16.
169. Martin, W. R., Wikler, A., Eades, C. G. & Pescor, F. T. (1963). Tolerance to and physical dependence on morphine in rats. Psychopharmacology 4, 247–60.
170. Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E. & Gilbert, P. E. (1976). The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197, 517–32.
171. Mattia, A., Vanderah, T., Mosberg, H. I. & Porreca, F. (1991). Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]-enkephalin and [DAla2]-deltorphan II in mice: evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther. 258, 583–7.
172. McLaughlin, C. L. & Baile, C. A. (1983). Nalmefene decreases meal size, food and water intake and weight gain in Zucker rats. Pharmacol. Biochem. Behav. 19, 235–40.
173. McLaughlin, C. L. & Baile, C. A. (1984). Feeding behavior responses of Zucker rats to naloxone. Physiol. Behav. 32, 755–61.
174. McLean, S. & Hoebel, B. G. (1982). Opiate and norepinephrine-induced feeding from the paraventricular nucleus of the hypothalamus are dissociable. Life Sci. 31, 2379–82.
175. Mehiel, R. (1996). The effects of naloxone on flavor-calorie preference learning indicate involvement of opioid reward systems. Psychol. Rec. 46, 435–50.
176. Meunier, J. C., Mollereau, C., Toll, L. et al. (1995). Isolation and structure of the endogenous agonist of the opioid receptor like ORL1 receptor. Nature 377, 532–5.
177. Millan, M. J. & Morris, B. J. (1988). Long-term blockade of mu-opioid receptors suggests a role in control of ingestive behavior, body weight and core temperature in the rat. Brain Res. 450, 247–58.
178. Morley, J. E. & Levine, A. S. (1980). Stress-induced eating is mediated through endogenous opiates. Science 209, 1259–61.
179. Morley, J. E. & Levine, A. S. (1981). Dynorphin (1–13) induces spontaneous feeding in rats. Life Sci. 29, 1901–3.
180. Morley, J. E. & Levine, A. S. (1983). Involvement of dynorphin and the kappa opioid receptor in feeding. Peptides 4, 797–800.
181. Morley, J. E., Levine, A. S., Grace, M. & Kneip, J. (1982). An investigation of the role of kappa opiate receptors in the initiation of feeding. Life Sci. 31, 2617–26.
182. Morley, J. E., Levine, A. S., Kneip, J., Grace, M., Zeugner, H. & Shearman, G. T. (1985). The K opioid receptor and food intake. Eur. J. Pharmacol. 112, 17–25.
183. Mucha, R. F. & Iversen, S. D. (1986). Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat. Brain Res. 397, 214–24.
184. Myers, K. J. & Dean, N. M. (2000). Sensible use of antisense: how to use oligonucleotides as research tools. Trends Pharmacol. Sci. 21, 19–23.
185. Nencini, P. & Stewart, J. (1990). Chronic systemic administration of amphetamine increases food intake to morphine, but not to U50488H, microinjected into the ventral tegmental area in rats. Brain Res. 527, 254–8.
186. Nock, B., Rajpara, A., O’Connor, L. H. & Cicero, T. J. (1988). Autoradiography of [3-H]-U69,593 binding sites in rat brain: evidence for K opioid receptor subtypes. Eur. J. Pharmacol. 154, 27–34.
187. Noel, M. B. & Wise, R. A. (1993). Ventral tegmental injections of morphine but not U50488H enhance feeding in food-deprived rats. Brain Res. 632, 68–73.
188. Noel, M. B. & Wise, R. A. (1995). Ventral tegmental injections of a selective mu or delta opioid enhance feeding in food-deprived rats. Brain Res. 673, 304–12.
189. O’Hare, E., Cleary, J. P., Billington, C. J. & Levine, A. S. (1997). Naloxone administration following operant training of sucrose/water discrimination in the rat. Psychopharmacology 129, 289–94.
190. Olson, G. A., DeLatte, S. W., Kastin, A. J., McLean, J. H., Phillpott, D. F. & Olson, R. D. (1985). Naloxone and fluid consumption in rats: dose-response relationship for 15 days. Pharmacol. Biochem. Behav. 23, 1065–8.
191. Olszewski, P. K., Grace, M. K., Billington, C. J. & Levine, A. S. (2000). The effect of [Phe (1)psi(CH(2)-NH)Gly(2)]-nociceptin(1–13)NH(2) on feeding and c-Fos immunoreactivity in selected brain sites. Brain Res. 876, 95–102.
192. Ostrowski, N. L., Rowland, N., Foley, T. L., Nelson, J. L. & Reid, L. D. (1981). Morphine antagonists and consummatory behaviors. Pharmacol. Biochem. Behav. 14, 549–59.
193. Pan, Y. X., Xu, J., Bolan, E. et al. (1999). Identification and characterization of three new alternatively spliced MOR-1 opioid receptor isoforms. Mol. Pharmacol. 56, 396–403.
194. Pan, Y. X., Xu, J., Mahurter, L., Bolan, E., Xu, M. & Pasternak, G. W. (2001). Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc. Natl. Acad. Sci. USA 98, 14084–9.
195. Papadouka, V. & Carr, K. D. (1994). The role of multiple opioid receptors in the maintenance of stimulation-induced feeding. Brain Res. 639, 42–8.
196. Parker, L. A., Maier, S., Rennie, M. & Crebolder, J. (1992). Morphine- and naltrexoneinduced modification of palatability: analysis by the taste reactivity test. Behav. Neurosci. 106, 999–1010.
197. Pasternak, G. W. & Standifer, K. M. (1995). Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. Trends Pharmacol. Sci. 16, 344–50.
198. Pasternak, G. W. & Wood, P. L. (1986). Multiple mu opiate receptors. Life Sci. 38, 1889–96.
199. Pecina, S. & Berridge, K. (2000). Opioid site in nucleus accumbens shell mediates eating and hedonic ‘liking’ for food: map based on microinjection Fos plumes. Brain Res. 863, 71–86.
200. Pert, C. B. & Snyder, S. H. (1973). Opiate receptor: demonstration in nervous tissue. Science 179, 1011–14.
201. Plata-Salaman, C. R., Wilson, C. D., Sonti, G., Borkoski, J. P. & ffrench-Mullen, J. M. H. (1995). Antisense oligodeoxynucleotides to G-protein alpha-subunit subclasses identify a transductional requirement for the modulation of normal feeding dependent on Goa alpha subunit. Mol. Brain Res. 33, 72–8.
202. Polidori, C., deCaro, G. & Massi, M. (2000). The hyperphagic effect of nociceptin/orphanin FQ in rats. Peptides 21, 1051–62.
203. Pomonis, J. D., Billington, C. J. & Levine, A. S. (1996). Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. Neuroreport 8, 369–71.
204. Pomonis, J. D., Jewett, D. C., Kotz, C. M., Briggs, J. E., Billington, C. J. & Levine, A. S. (2000). Sucrose consumption increases naloxone-induced c-fos immunoreactivity in limbic forebrain. Am. J. Physiol. 278, R712–19.
205. Quinn, J. G., O’Hare, E., Levine, A. S. & Kim, E. M. (2003). Evidence for a mu-opioidopioid connection between the paraventricular nucleus and ventral tegmental area in the rat. Brain Res. 991, 206–11.
206. Ragnauth, A., Ruegg, H. & Bodnar, R. J. (1997). Evaluation of opioid receptor subtype antagonist effects in the ventral tegmental area upon food intake under deprivation, glucoprivic and palatable conditions. Brain Res. 767, 8–16.
207. Ragnauth, A., Moroz, M. & Bodnar, R. J. (2000). Multiple opioid receptors mediate feeding elicited by mu and delta opioid receptor subtype agonists in the nucleus accumbens shell in rats. Brain Res. 876, 76–87.
208. Ragnauth, A., Schuller, A., Morgan, M. et al. (2001). Female preproenkephalinknockout mice display altered emotional responses. Proc. Natl. Acad. Sci. USA 98, 1958–63.
209. Ramirez, I. (1997). Intragastric carbohydrate exerts both intake-stimulating and intake-suppressing effects. Behav. Neurosci. 111, 612–22.
210. Recant, L., Voyles, N. R., Luciano, M. & Pert, C. B. (1980). Naltrexone reduced weight gain, alters beta-endorphin and reduces insulin output from pancreatic islets of genetically obese mice. Peptides 1, 309–13.
211. Reicine, T. & Bell, G. I. (1993). Molecular biology of opioid receptors. Trends Neurosci. 16, 506–10.
212. Reinscheid, R. K., Nothacker, H. P., Bourson, A. et al. (1995). Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science 270, 792–4.
213. Rizzi, A., Salis, M. B., Ciccocioppo, R. et al. (2002). Pharmacological characterisation of [(pX)Phe4]nociceptin(1–13)NH2 analogues. 2. In vivo studies. Naunyn Schmiedebergs Arch. Pharmacol. 365, 450–6.
214. Roberts, J. L., Seeburg, P. H., Shine, J., Herbert, E., Baxter, J. D. & Goodman, H. M. (1979). Corticotropin and b-endorphin: construction of analysis of recombinant DNA complementary to mRNA for the common precursor. Proc. Natl. Acad. Sci. USA 76, 2153–7.
215. Rodi, D., Polidori, C., Bregola, G., Zucchini, S., Simonato, M. & Massi, M. (2002). Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats. Brain Res. 957, 354–61.
216. Roerig, S. C. (1998). Opioid regulation of secondmessenger systems. Analgesia 3, 231–50.
217. Rossi, G. C., Standifer, K. M. & Pasternak, G. W. (1995). Differential blockade of morphine and morphine-6B-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats. Neurosci. Lett. 198, 99–102.
218. Rossi, G. C., Leventhal, L., Pan, Y.-X. et al. (1997). Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception. J. Pharmacol. Exp. Ther. 281, 109–14.
219. Rowland, N. (1982). Comparison of the suppression by naloxone of water intake induced in rats by hyperosmolarity, hypovolemia and angiotensin. Pharmacol. Biochem. Behav. 16, 87–91.
220. Rowland, N. & Bartness, T. J. (1982). Naloxone suppresses insulin-induced food intake in novel and familiar environments, but does not affect hypoglycemia. Pharmacol. Biochem. Behav. 16, 1001–3.
221. Rudski, J. M., Schaal, D. W., Thompson, T., Cleary, J., Billington, C. J. & Levine, A. S. (1992). Effects of methadone on free feeding in satiated rats. Pharmacol. Biochem. Behav. 43, 1033–7.
222. Rudski, J. M., Billington, C. J. & Levine, A. S. (1994). Naloxone’s effects on operant responding depend upon level of deprivation. Pharmacol. Biochem. Behav. 49, 377–83.
223. Rudski, J. M., Thomas, D., Billington, C. J. & Levine, A. S. (1995). Buprenorphine increases intake of freely available and operant-contingent food in satiated rats. Pharmacol. Biochem. Behav. 50, 271–6.
224. Ruegg, H., Hahn, B., Koch, J. E. & Bodnar, R. J. (1994). Differential modulation of angiotensin II and hypertonic saline-induced drinking by opioid receptor subtype antagonists in rats. Brain Res. 635, 203–10.
225. Ruegg, H., Yu, W.-Z. & Bodnar, R. J. (1997). Opioid receptor subtype agonist-induced enhancements of sucrose intake are dependent upon sucrose concentration. Physiol. Behav. 62, 121–8.
226. Sanger, D. J. (1981). Endorphinergic mechanisms in the control of food and water intake. Appetite 2, 193–208.
227. Sanger, D. J. & McCarthy, P. S. (1980). Differential effects of morphine on food and water intake in food deprived and freely feeding rats. Psychopharmacology 72, 103–6.
228. Sanger, D. J. & McCarthy, P. S. (1981). Increased food and water intake produced by rats by opiate receptor agonists. Psychopharmacology 74, 217–20.
229. Schulz, R., Wilhelm, A. & Dirlich, G. (1984). Intracerebral microinjection of different antibodies against the endogenous opioids suggests alpha-neoendorphin participation in control of feeding behavior. Naunyn Schmiedebergs Arch. Pharmacol. 326, 222–6.
230. Shaw, W. N., Mitch, C. H., Leander, J. D. & Zimmerman, D. M. (1990). Effect of phenylpiperidine opioid antagonists on food consumption and weight gain of the obese Zucker rat. J. Pharmacol. Exp. Ther. 253, 85–9.
231. Shide, D. J. & Blass, E. M. (1991). Opioid mediation of odor preferences induced by sugar and fat in 6-day-old rats. Physiol. Behav. 50, 961–6.
232. Shimomura, Y., Oku, J., Glick, Z. & Bray, G. A. (1982). Opiate receptors, food intake and obesity. Physiol. Behav. 28, 441–5.
233. Silva, R. M., Rossi, G. C., Mathis, J. P., Standifer, K. M., Pasternak, G. W. & Bodnar, R. J. (2000). Morphine and morphine-6beta-glucuronide-induced feeding are differentially reduced by G-protein alpha-subunit antisense probes in rats. Brain Res. 876, 62–75.
234. Silva, R. M., Hadjimarkou, M. M., Rossi, G. C., Pasternak, G. W. & Bodnar, R. J. (2001). Beta-endorphin-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats. J. Pharmacol. Exp. Ther. 297, 590–6.
235. Silva, R. M., Grossman, H. C., Hadjimarkou, M. M., Rossi, G. C., Pasternak, G. W. & Bodnar, R. J. (2002a). Dynorphin A1-17-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats. J. Pharmacol. Exp. Ther. 301, 513–18.
236. Silva, R. M., Grossman, H. C., Rossi, G. C., Pasternak, G. W. & Bodnar, R. J. (2002b). Pharmacological characterization of beta-endorphin- and dynorphin A-induced feeding using g-protein alpha subunit antisense probes in rats. Peptides 23, 1101–6.
237. Simon, E. J., Hiller, J. M. & Edelman, I. (1973). Stereospecific binding of the potent narcotic analgesic (3H)etorphine to rat brain homogenate. Proc. Natl. Acad. Sci. USA 70, 1947–9.
238. Simone, D. A., Bodnar, R. J., Goldman, E. J. & Pasternak, G. W. (1985). Involvement of opioid receptor subtypes in rat feeding behavior. Life Sci. 36, 829–33.
239. Sipols, A. J., Bayer, J., Bennett, R. & Figlewicz, D. P. (2002). Intraventricular insulin decreases kappa opioid-mediated sucrose intake in rats. Peptides 23, 2181–7.
240. Siviy, S. M., Bermudez-Rattoni, F., Rockwood, G. A., Dargie, C. M. & Reid, L. D. (1981). Intracerebral administration of naloxone and drinking in water-deprived rats. Pharmacol. Biochem. Behav. 15, 257–62.
241. Smith, G. P. (1996). The direct and indirect controls of meal size. Neurosci. Biobehav. Rev. 20, 41–6.
242. Spencer, R. L., Deupree, D., Hsiao, S. et al. (1986). Centrally-administered opioid selective agonists inhibit drinking in the rat. Pharmacol. Biochem. Behav. 25, 77–82.
243. Standifer, K. M., Chien, C. C., Wahlestedt, C., Brown, G. P. & Pasternak, G. W. (1994). Selective loss of delta opioid analgesia and binding by oligodeoxynucleotides to a delta opioid receptor. Neuron 12, 805–10.
244. Standifer, K. M., Jenab, S., Su, W. et al. (1995). Antisense oligodeoxynucleotides to the cloned receptor, DOR-1: Uptake, stability and regulation of gene expression. J. Neurochem. 65, 1981–7.
245. Standifer, K. M., Rossi, G. C. & Pasternak, G. W. (1996). Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits. Mol. Pharmacol. 50, 293–8.
246. Stanley, B. G., Lanthier, D. & Leibowitz, S. F. (1989). Multiple brain sites sensitive to feeding stimulation by opioid agonists: a cannula-mapping study. Pharmacol. Biochem. Behav. 31, 825–32.
247. Stein, J. A., Znamensky, V., Baumer, F., Rossi, G. C., Pasternak, G. W. & Bodnar, R. J. (2000). Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats. Brain Res. 864, 240–51.
248. Stratford, T. R., Holahan, M. R. & Kelley, A. E. (1997). Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. Neuroreport 8, 423–6.
249. Summy-Long, J. Y., Rosella, L. M. & Keil, L. C. (1981). Effects of centrally administered endogenous opioid peptides on drinking behavior, increased plasma vasopressin concentration and pressor response to hypertonic sodium chloride. Brain Res. 221, 343–57.
250. Sweet, D. C., Levine, A. S. & Kotz, C. M. (2004). Functional opioid pathways are necessary for hypocretin-1 (orexin-A)-induced feeding. Peptides 25, 307–14.
251. Tang, A. H. & Collins, R. J. (1985). Behavioral effects of a novel kappa opioid analgesic, U50488, in rats and rhesus monkeys. Psychopharmacology 85, 309–14.
252. Tepperman, F. S. & Hirst, M. (1983). Effects of intrahypothalamic injection of D-Ala-2, D-Leu-5-enkephalin on feeding and temperature in the rat. Eur. J. Pharmacol. 96, 243–9.
253. Tepperman, F. S., Hirst, M. & Gowdey, C. W. (1981). Hypothalamic injection of morphine: feeding and temperature responses. Life Sci. 28, 2459–67.
254. Terenius, L. (1973). Stereospecific interaction between narcotic analgesia and a synaptic plasma membrane fraction of rat cerebral cortex. Acta Pharmacol. Toxicol. 32, 317–20.
255. Thornhill, J. A., Taylor, B., Marshall, W. & Parent, K. (1982). Central, as well as peripheral naloxone administration suppresses feeding in food-deprived Sprague-Dawley and genetically obese (Zucker) rats. Physiol. Behav. 29, 841–6.
256. Tsujii, S., Nakai, Y., Fukata, J. et al. (1986a). Effects of food deprivation and high fat diet on opioid receptor binding in rat brain. Neurosci. Lett. 72, 169–73.
257. Tsujii, S., Nakai, Y., Koh, T. et al. (1986b). Effects of food deprivation on opioid receptor binding in the brain of lean and fatty Zucker rats. Brain Res. 399, 200–3.
258. Uhl, G. R., Childers, S. R. & Pasternak, G. W. (1994). An opiate receptor gene family reunion. Trends Neurosci. 17, 89–93.
259. Ukai, M. & Holtzman, S. G. (1988a). Effects of beta-funaltrexamine on ingestive behaviors in the rat. Eur. J. Pharmacol. 153, 161–5.
260. Ukai, M. & Holtzman, S. G. (1988b). Effects of intrahypothalamic administration of opioid peptides selective for mu, kappa and delta receptors on different schedules of water intake in rats. Brain Res. 459, 275–81.
261. Ukai, M., Nakayama, S. & Kameyama, T. (1988). The opioid antagonist, MR2266, specifically decreases saline intake in the mouse. Neuropharmacology 27, 1027–31.
262. Wahlestedt, C. (1994). Antisense oligodeoxynucleotide strategies in neuropharmacology. Trends Pharmacol. Sci. 15, 42–6.
263. Walker, J. M., Katz, R. J. & Akil, H. (1980). Behavioral effects of dynorphin (1–13) in the mouse and rat: initial observations. Peptides 1, 341–5.
264. Welch, C. C., Grace, M. K., Billington, C. J. & Levine, A. S. (1994). Preference and diet type affect macronutrient selection after morphine, NPY, norepinephrine, and deprivation. Am. J. Physiol. 266, R426–33.
265. Welch, C. C., Kim, E.-M., Grace, M. K., Billington, C. J. & Levine, A. S. (1996). Palatability-induced hyperphagia increases hypothalamic dynorphin peptide and mRNA levels. Brain Res. 721, 126–31.
266. Wilson, J. D., Nicklous, D. M., Aloyo, V. J. & Simansky, K. J. (2003). An orexigenic role for mu-opioid receptors in the lateral parabrachial nucleus. Am. J. Physiol. 285, R1055–65.
267. Wolinsky, T. D., Carr, K. D., Hiller, J. M. & Simon, E. J. (1994). Effects of chronic food restriction on mu and kappa opioid binding in rat forebrain: a quantitative autoradiographic study. Brain Res. 656, 274–80.
268. Wolinsky, T. D., Abrahamsen, G. C. & Carr, K. D. (1996a). Diabetes alters mu and kappa opioid binding in rat brain: comparison with effects of food restriction. Brain Res. 738, 167–71.
269. Wolinsky, T. D., Carr, K. D., Hiller, J. M. & Simon, E. J. (1996b). Chronic food restriction alters mu and kappa opioid receptor binding in the parabrachial nucleus of the rat: a quantitative autoradiographic study. Brain Res. 706, 333–6.
270. Wolozin, B. L. & Pasternak, G. W. (1981). Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc. Natl. Acad. Sci. USA 78, 6181–5.
271. Woods, J. S. & Leibowitz, S. F. (1985). Hypothalamic sites sensitive to morphine and naloxone: effects on feeding behavior. Pharmacol. Biochem. Behav. 23, 431–8.
272. Yirmiya, R., Lieblich, I. & Liebeskind, J. C. (1988). Reduced saccharin preference in CXBK (opioid receptor-deficient) mice. Brain Res. 438, 339–42.
273. Yu, W.-Z. & Bodnar, R. J. (1997). Interactions between Angiotensin II and delta opioid receptor subtype agonists upon water intake in rats. Peptides 18, 241–5.
274. Yu, W.-Z., Ruegg, H. & Bodnar, R. J. (1997). Delta and kappa opioid receptor subtypes and ingestion: antagonist and glucoprivic effects. Pharmacol. Biochem. Behav. 56, 353–61.
275. Yu, W.-Z., Sclafani, A., Delamater, A. R. & Bodnar, R. J. (1999). Pharmacology of flavor preference conditioning in sham-feeding rats: effects of naltrexone. Pharmacol. Biochem. Behav. 64, 573–84.
276. Zadina, J. E., Hackler, L., Ge, L.-J. & Kastin, A. J. (1997). A potent and selective endogenous agonist for the mu-opiate receptor. Nature 386, 499–502.
277. Zhang, M. & Kelley, A. E. (2000). Enhanced intake of high-fat food following striatal mu-opioid stimulation: microinjection mapping and fos expression. Neuroscience 99, 267–77.
278. Zhang, M. & Kelley, A. E. (2002). Intake of saccharin, salt, and ethanol solutions is increased by infusion of a mu opioid agonist into the nucleus accumbens. Psychopharmacology 159, 415–23.
279. Zhang, M., Gosnell, B. A. & Kelley, A. E. (1998). Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J. Pharmacol. Exp. Ther. 285, 908–14.
280. Zukin, R. S., Eghbalai, M., Olive, D., Unterwald, E. M. & Tempel, A. (1988). Characterization and visualization of rat and guinea pig brain K opioid receptors: evidence for K-1 and K-2 opioid receptors. Proc. Natl. Acad. Sci. USA 85, 4061–5.